Okava has been investigating the use of GLP-1 receptors in cats and found it has similar effects to weight-loss drugs on humans.
The San Francisco-based company is hoping to develop a long-acting implant as opposed to regular injections.
But, Healthy Pets New Zealand trustee and vet Dr Cath Watson says weight loss drugs should not be the first option for pets.
Watson told Andrew Dickens that pet obesity levels are "pretty bad and getting worse".
LISTEN ABOVE

Perspective with Heather du Plessis-Allan: The attention on the Waikato ED case could increase the odds of fixing the problem
02:06

Full Show Podcast: 03 July 2026
1:40:38

Perspective with Heather du Plessis-Allan: What real employer would do what the Ministry of Justice did?
02:25